Curaleaf Holdings (CURLF) EBT Margin (2019 - 2026)
Curaleaf Holdings (CURLF) recorded quarterly EBT Margin of 8.83% in Q1 2026, up 100.0% quarter-over-quarter from 7243565.88% in Q4 2025, and down 348.0% on a YoY basis from 3.56% in Q1 2025.
Curaleaf Holdings (CURLF) EBT Margin (2019 - 2026) Analysis & Trends
Curaleaf Holdings' EBT Margin history runs 8 years deep, the most recent figure standing at 8.83% for Q1 2026.
- In Q1 2026, EBT Margin fell 348.0% year-over-year to 8.83%; the TTM figure through Mar 2026 stood at 6727.39% (down 671831.0% YoY), while the FY2025 annual figure was 6.17%, up 233.0% from the prior year.
- EBT Margin was 8.83% for Q1 2026 at Curaleaf Holdings, up from 7243565.88% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 9.79% in Q2 2022 to a low of 17559062.64% in Q4 2023.
- Historically, EBT Margin has averaged 1932123.24% across 5 years, with a median of 7.47% in 2025.
- The sharpest annual moves came in 2023 and 2024: EBT Margin sank 1755899170 bps in 2023, then jumped 1755904002 bps in 2024.
- A 5-year view of EBT Margin shows it stood at 70.94% in 2022, then slumped by 24751442 bps to 17559062.64% in 2023, then soared by 100 bps to 22.62% in 2024, then sank by 32023192 bps to 7243565.88% in 2025, then jumped by 100 bps to 8.83% in 2026.
- The last three EBT Margin figures came in at 8.83% (Q1 2026), 7243565.88% (Q4 2025), and 7.59% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 10.97% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 33.51% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 40.73% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 25.87% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 30.30% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.35% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -156.77% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 41.45% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -16.70% |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | -8.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.83% |
| Dec 31, 2025 | -7,243,565.88% |
| Sep 30, 2025 | -7.59% |
| Jun 30, 2025 | -6,111,217.09% |
| Mar 31, 2025 | -5.35% |
| Dec 31, 2024 | -22.62% |
| Sep 30, 2024 | -3.56% |
| Jun 30, 2024 | -5.01% |
| Mar 31, 2024 | -3.39% |
| Dec 31, 2023 | -17,559,062.64% |
| Sep 30, 2023 | -10.79% |
| Jun 30, 2023 | -7.34% |
| Dec 31, 2022 | -70.94% |
| Sep 30, 2022 | 2.63% |
| Jun 30, 2022 | 9.79% |
| Mar 31, 2022 | 6.86% |
| Dec 31, 2021 | -13.11% |
| Sep 30, 2021 | 0.84% |
| Jun 30, 2021 | 11.06% |
| Mar 31, 2021 | 6.11% |